N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide
C29H28FN3O3 — CID 11583921
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide
N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide (PubChem CID 11583921) has the molecular formula C29H28FN3O3 and a molecular weight of 485.56 g/mol. Its IUPAC name is N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide.
Molecular Properties
| Compound Name | N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide |
|---|---|
| PubChem CID | 11583921 |
| Molecular Formula | C29H28FN3O3 |
| Molecular Weight | 485.56 g/mol |
| Exact Mass | 485.21 |
| IUPAC Name | N-[[2-fluoro-5-(1H-indol-5-yl)phenyl]methyl]-N-(1-methylpiperidin-4-yl)-1,3-benzodioxole-5-carboxamide |
| SMILES | CN1CCC(N(Cc2cc(-c3ccc4[nH]ccc4c3)ccc2F)C(=O)c2ccc3c(c2)OCO3)CC1 |
| InChI | InChI=1S/C29H28FN3O3/c1-32-12-9-24(10-13-32)33(29(34)22-4-7-27-28(16-22)36-18-35-27)17-23-15-19(2-5-25(23)30)20-3-6-26-21(14-20)8-11-31-26/h2-8,11,14-16,24,31H,9-10,12-13,17-18H2,1H3 |
| InChIKey | HPXVEQFJLMKKQR-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 57.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.56 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11583921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.